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    The hypoplastic left heart syndrome (HLHS) is one of the rarest congenital heart diseases 
affecting infants. Out of 150 babies born, one baby suffers from congenital heart disease. 
Furthermore, nine percent out of those suffering from congenital heart disease specifically 
suffer from hypoplastic left heart syndrome (HLHS). To this end, the Fontan operation 
which is a procedure to generate a harmonic blood flow in single functioning ventricle 
patients has been executed to palliate HLHS patients. In this operation, the inferior vena 
cava (IVC) and the superior vena cava (SVC), carrying the low-oxygenated blood returning 
from the lower and upper body back to the heart, are connected to the pulmonary arteries. 
Despite the fact that the Fontan operation has been executed for years, it is still not the 
effective palliation to heal HLHS patients since those who have undergone this procedure 
experience chronic diseases. In order to mitigate the risk associated with the Fontan 
procedure, an Injection Jet Shunt (IJS) is suggested to connect the aorta to the total 
cavopulmonary connection (TCPC). Thus, the purpose of utilizing the IJS is to add 
momentum to the pulmonary arteries. This research is concerning two models, baseline 
model and IJS model. Those two models represent a simplified Fontan physiology. The 
purpose of this research is to distinguish the effectiveness of using the IJS.     
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Chapter I 
Introduction 
 
Background 
 
        Infants who are born with a single functioning heart ventricle go through a sequence 
of surgical operations to attain the best possible cardiac output out of the single functioning 
heart ventricle. This issue is related to hypoplastic left heart syndrome (HLHS) [1] [2].  The 
hypoplastic left heart syndrome (HLHS) is a scarce congenital heart disease. This 
syndrome means the left heart is severely underdeveloped. The left heart consists of the left 
ventricle, the mitral valve, the aortic valve, and the ascending part of the aorta. In general, 
this syndrome may cause some undefeated issues to the patients. Single ventricle issue is 
one of the many congenital cardiac disorders. 50% of patients reaching the age of 20 face 
a death risk since the right ventricle is not pumping the blood efficiently [3]. Figure (1) 
below displays how the left heart is underdeveloped. 
 Figure 1: Hypoplastic Left Heart Syndrome [4] 
 
Figure 2: Hypoplastic Left Heart Syndrome 
 
Source: [9]Figure 3: Hypoplastic Left Heart Syndrome 
 
Figure 4: Hypoplastic Left Heart Syndrome 
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        The main variance in the human cardiovascular anatomy for the normal human 
heart and the unhealthy heart suffering from HLHS is palliative procedures that are 
performed in the following three consecutive stages. The first stage is called Norwood 
procedure. In this stage, the hypoplasic aorta is rejoined to the right ventricle rather than 
link it to the pulmonary root. Furthermore, the second stage concerning the Glenn 
procedure, the superior vena cava (SVC) is separated from the right atrium and linked 
straight to the right pulmonary artery. Finally, the last stage is named as Fontan 
procedure. The inferior vena cava (IVC) is separated from the right atrium and 
connected straight to the pulmonary arteries. This procedure produces a total 
cavopulmonary connection [5]. 
 Research Significance 
 
        This research concentrates on patients suffering from a single ventricle heart disease 
(HLHS). As mentioned earlier in this research, there are three consecutive stages that need 
to be followed in order to improve the cardiovascular system. This research is focusing 
practically on the third stage which is the Fontan surgery. This study helps comprehend the 
advantage of adding the injection jet shunt (IJS) to the original procedure. The role of the 
injection jet shunt is to link the ascending aorta to the total cavopulmonary connection 
(TCPC).  
 Research Objective 
 
        The objective of this study is to validate the utilization of the injection jet shunt in the 
Fontan procedure by relying on a commercial software called Star-CCM+ as well as Catia 
V5 used to build the geometry.  
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Research Approach 
 
     To complete the research objective, the following steps will be conducted as follow: 
a. Step1- Literature review: previous comprehensive studies about the Fontan 
procedure 
b. Step 2- building the baseline model as well as the IJS model by using Catia V5 to 
assist the CFD analysis in Star CCM+ software.  
c. Step3- Comparison Analysis: comparing the results between the baseline model and 
the aftermath of adding the IJS to the baseline model. 
d. Step4: Procedure improvement: based on the results provided, the importance of the 
IJS is being explained, and the cardiac output will be enhanced.  
 
Research Layout 
 
     This research will be presented in five chapters. The summary of each chapter will be 
addressed as follow: 
a. Chapter one- Introduction: a brief description of the importance of this study in the 
medical and engineering fields will be summarized in this chapter. 
b. Chapter two – Literature Review: This chapter offers a complete review of previous 
research that has been done in the medical and engineering fields. 
c. Chapter three - Methodology: a detailed illustration about conducting two models 
by using the CFD analysis. 
d. Chapter four – Results and Discussions: the results obtained from the CFD analysis 
will be discussed and demonstrated in this chapter.  
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e. Chapter Five – Conclusion, limitation, and future work: the main findings derived 
from this study will be presented, also, several recommendations will be suggested 
for further research work. 
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                                                   Chapter II 
Review of the Relevant Literature 
 
Heart Physiology 
 
         The cardiovascular system contains the heart, a unique organ of the human body, 
placed in the middle of the body and the vessels of the body that help convey the blood. 
This system provides oxygen, obtained from the air through the lungs, to the organs 
throughout the body. It is also responsible for the deletion of the waste in the body. The 
blood circulation is also responsible for moving nutrients like amino acids, and others. [6] 
[7]. Furthermore, the heart consists of two sides, the left and right side. The right side of 
the heart is in charge of pumping the blood to the lungs, and it works by receiving the poor-
oxygenated blood through veins to the right ventricle, and then through the tricuspid valve 
to the lungs to get oxygenated. While the left side of heart is responsible for pushing the 
blood to the rest of the body. It starts when the left atrium receives the red blood through 
the mitral valve [8]. Figure (2) below shows the cardiovascular system. 
Figure 2: The cardiovascular system [9] 
 
Source: [19] 
Figure 3: Norwood Procedure 
 
 
Source: [22]Source: [19]Source: [9] 
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Hypoplastic Left Heart Syndrome 
 
        Many patients around the globe have a congenital heart disease (CHD), the most 
common reason of a major congenital abnormality, demonstrating key universal health 
difficulties. Twenty-eight percent of all main congenital abnormalities involve heart 
failings [10]. One of the rarest problems occurs to the infants is the hypoplastic left heart 
syndrome (HLHS) that distresses normal blood flow through the heart.  
 
        This happens when infants grow through pregnancy, the left side of the heart does not 
form properly [11]. The reasons why the left side of the heart is not performing properly is 
because mitral valve, left ventricle, aortic valve, and the ascending portion of the aorta are 
severely underdeveloped. Usually, an infant with hypoplastic left heart syndrome (HLHS), 
the left side of the heart cannot pump blood to the other organs efficiently. In situations 
similar to that, the right side of the heart will be responsible for pumping the blood to the 
whole body [12]. 
 
        The hypoplastic left heart syndrome (HLHS) embodies fully nine percent of those 
with congenital heart disease (CHD). If infants being left without medical treatment, the 
defect is nearly without doubt lethal [13]. In general, there is no gene is directly associated 
to the hypoplastic left heart syndrome (HLHS). But, many genetic relations have been 
recognized without any reliable marker [14]. Even though lethal if left untouched, this 
defect is exceedingly curable with reconstructive surgical procedures that will be addressed 
in this research.  
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Norwood Procedure  
 
        The Norwood procedure was presented as the first stage surgical procedure for infants 
with hypoplastic left heart syndrome (HLHS). It has later been applied to many cardiac 
flaws determined by the existence of a practical single ventricle with complete outflow 
tract block [15].  
 
       This procedure is performed right after the birth [14]. Many of the infants leave the 
hospital between ten days to two weeks after the end of the Norwood operation. The 
procedure works when the right ventricle is linked to a rebuilt aorta with the use of the near 
core pulmonary artery for the systemic outflow. A shunt from the pulmonary artery to the 
systemic circulation helps regenerating the pulmonary blood flow [16].  
                 The Norwood procedure tries to avoid cardiopulmonary bypass and contains of a stent 
of the ductus arteriosus, balloon atrial septostomy, and a branch pulmonary artery banding.  
 
        The less disturbing environment of the Norwood procedure and deferral of the danger 
of a main open-heart operation to an older age are meant to help improve survival, 
neurologic, and cardiac practical outcomes. Latest reports of survival after the Norwood 
procedure are as good as with those achieved with the conventional surgical Norwood. 
Furthermore, the Norwood procedure has turned out to be the favored first operation for 
HLHS mitigation [17].  
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       The expansion of Norwood stage mitigation significantly enhanced the outcome of the 
newborns with HLHS. Conversely, with the substantial development in surgical operation, 
this procedure is a practical experiment and still holds major mortality and sickness [18]. 
Below, figure (3) displays the Norwood procedure. 
 
 
Bidirectional Glenn Procedure 
 
        The bidirectional Glenn procedure (BDG) that is also called the hemi-Fontan (HF) 
operation is the second stage in the process to a crucial Fontan mitigation. Even though the 
bidirectional Glenn procedure (BDG) is predominant in the Western world, it has faced 
limited utilization in the evolving world [20]. This procedure is executed at six to eight 
Figure 3: Norwood Procedure [19] 
 
 
Source: [22]Source: [19] 
Figure 10: Norwood Procedure 
 
 
Source: [22] 
Figure 4: Bidirectional Glenn procedure 
 
Source: [28]Source: [22]Source: [19] 
Figure 3: Norwood Procedure 
 
 
Source: [22]Source: [19] 
Figure 11: Norwood Procedure 
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months of babies’ age [14].  The perfect age to implement the bidirectional Glenn 
procedure (BDG), however, stays indeterminate [21]. 
       The bidirectional Glenn procedure (BDG) helps involve connection of the superior 
vena cava to the pulmonary artery [6]. It also assists enhancing the efficiency of gas 
exchange without concerning about volume or pressure overload of the ventricle 
contrasting the pulmonary trunk band or systemic-pulmonary arterial shunt. After the 
bidirectional Glenn procedure (BDG) is done, the medical definition of the idea of total 
cavopulmonary connection (TCPC) has been started [6]. Even though it enhances overall 
survival, there is a number of babies who might be at a credible hazard [20]. Typically, the 
bidirectional Glenn procedure (BDG) is a valuable intermediate comforting operation prior 
to the Fontan operation. Figure (4) shows the Bidirectional Glenn procedure. 
 
Figure 4: Bidirectional Glenn procedure [22] 
 
Source: [28]Source: [22] 
Figure 12: Bidirectional Glenn procedure4 
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Fontan Procedure 
 
        The Fontan procedure is the last palliative operation for patients with hypoplastic left 
heart syndrome (HLHS) [23].  It was established in 1971 by a cardiac surgeon, Francis 
Fontan [24] [25].  Usually, the procedure is performed to patients by the age of eighteen 
months to five years (most often near 4 years) [14].  
 
       The Fontan procedure has experienced several consecutive practical alterations. To 
illustrate, early alterations of this procedure linked the pulmonary arteries to the right 
atrium. Several approaches such as valve conduits, patches, and others were utilized. 
Initially, it was assumed that the right atrium would enhance the pulmonary blood flow. 
Conversely, de Leval found after conducting a number of experiments that the right atrium 
expanded, then the contractile function was weakened which caused an energy lack and 
essentially reduced pulmonary blood flow. Even though lots of efforts put to develop this 
technique, it is still considered obsolete [26]. 
 
       The second technique of the Fontan procedure was consequently enhanced to the 
lateral tunnel approach (LT). In this approach, the lateral tunnel Fontan utilizes a baffle 
within the right atrium (RA) and the superior vena cava (SVC) is stitched straight to the 
right pulmonary artery (RPA) [27]. 
       The latest technique is the extra-cardiac conduit (EC). The extra-cardiac Fontan 
operates an outer conduit to link the inferior vena cava (IVC) into the pulmonary arteries 
[27]. The Fontan is achieved in order to make poor-oxygenated blood coming back from 
the body go to the lungs. Figure (5) shows the stages of developing Fontan operation. 
11 
 
 
        Although, the Fontan procedure has many benefits toward patients with hypoplastic 
left heart syndrome (HLHS), it is still characterized by low cardiac output that is less 
reactive to normal physical stressors [29], high venous pressure, high pulmonary vascular 
resistance, and partially low arterial oxygen saturation [23]. Most likely, patients with a 
single ventricle who have undergone the Fontan procedure have liver disease (LD) [30]. 
Roughly, twenty one percent of patients who have gone through this procedure could have 
cirrhosis. Also, patients face numerous late obstacles such as heart failure, arrhythmia, and 
hepatic dysfunction [30]. 
 
 
 
 
 
Figure 5: The stages of Fontan procedure [28] 
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Chapter III 
Methodology 
 
Baseline Model 
 
         The 3D CAD model, representing a synthetic geometry of the cardiovascular system, 
was built by Catia V5. This model can be classified into five main parts which are: 
A. Aortic artery which is the major artery of the body responsible for 
supplying rich-oxygenated blood to the systemic circulations. 
B. Superior vena cava which is a large vein carrying blood through the 
upper systemic circulation  
C. Inferior vena cava which is a large vein responsible for carrying the 
blood in the lower systemic circulation back to the pulmonary arteries. 
D. Left and right pulmonary arteries which are carrying the blood coming 
from the systemic circulations back to the right atrium. 
E. Total cavopulmonary connection which is the Fontan procedure part 
representing where the systemic circulations and the pulmonary arteries 
connect. 
         The length of each part does not mimic what the real human’s cardiovascular system 
has since the blood journey through the body is too long and complicated. However, the 
diameters of each part were taken from Fontan patients who are by the age of 2 - 4 years 
old. The diameters of the aorta, inferior vena cava, superior vena cava, and pulmonary 
arteries are 18 mm, 18 mm, 12mm, and 9 mm consecutively [31]. Figure (6) below displays 
the synthetic CAD model. 
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Figure 6: Baseline Model 
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Injection Jet Shunt (IJS) 
 
         The research mainly focuses on the addition of the graft known as Injection Jet Shunt 
(IJS) to the Fontan procedure. The Injection Jet Shunt (IJS) basically connects the aorta to 
the pulmonary arteries.  This graft was modeled by Catia V5 in such a way to raise the flow 
in the pulmonary arteries by utilizing the mechanical energy obtained from the heart itself. 
The main determination of using the Injection Jet Shunt (IJS) is not only increasing the 
flow in the pulmonary arteries but also improving the blood circulation through the body, 
contributing in a better oxygen delivery, reducing the inferior vena cava pressure, and 
decreasing the loss of energy by adding pulse pressure to the pulmonary arteries. 
 
 
     The IJS is modeled with 3mm nozzles. This IJS model will be investigated and 
compared to the baseline model. This research will assist considering the use of the IJS 
connected to the Fontan procedure. Figure (7) below displays the Injection Jet Shunt of 
3mm diameter.  
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Figure 7: Injection Jet Shunt 
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Lumped Parameter Model 
 
        Various methods have been developed to evaluate and validate the blood flow in its 
long journey through the body. Experimental and numerical utilizing mathematical 
approaches have been done to simulate the circulatory system. This system can be 
represented by a state of Resistance –Inductance – Capacitance circuit (RLC circuit). To 
elaborate, the resistance stands for the static vascular resistance. The inductance represents 
the inertia of the flow while the capacitance describes the dynamic vascular compliance. 
The parameters of the (RLC circuit) are obtained by experimental and numerical 
simulations done to model the Fontan procedure. These parameters are arranged in to a 
system of ordinary differential equations by using the lumped parameter model to evaluate 
the blood flow and the pressure in the blood vessels. The Fontan procedure is represented 
by a system of 12 ordinary differential equations (12 DOF). These equations have been 
solved by a numerical method called Runge-Kutta 4th order solver. 
 
 
Figure 8: Lumped Parameter Model 
17 
 
        The basic concept of understanding the blood flow is basically accounted for the 
pressure difference at the inlet and outlet of each blood vessel. The blood vessels resist the 
blood flow passing through them, and that creates the resistance due to the friction between 
the blood flow and the stationary walls of the vessels. Once the pressure difference and the 
resistance exist, the blood flow can be easily represented by: 
 
              𝐹𝑙𝑜𝑤 =
𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒
𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒
         or         𝑄 =
𝑑𝑃
𝑅
………………………........(1) 
                Where Q = blood flow (ml/s)   
                𝑑P = pressure difference (mmHg) 
                R = resistance (mmHg - s/ ml) 
  
                  The blood vessels are compliant to the flow passing through them. This can be 
described   as follow: 
                           𝑄 = 𝐶 ∗  
𝑑𝑃
𝑑𝑡
……………………………….………………….….…… (2) 
                           𝐶 =
𝑑𝑉
𝑑𝑃
………………………………….…………………….….……(3) 
              Where C = Compliance coefficient (ml/mmHg) 
              dt = time step (s) 
              dV = change in volume ( 𝑚𝑚3) 
              While the inertia of the blood flow is represented by: 
                            𝑑𝑃 = 𝐿
𝑑𝑄
𝑑𝑡
…………………………………………………………....…..….(4) 
             Where dQ = flow change (ml/s) 
             L= Inertial flow coefficient (mmhg- 𝑠2/ ml) 
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       These differential equations have been arranged into a system of (12 DOF) in order to 
calculate the pressure and the flow in the blood vessels. The Fontan procedure has five 
lumped models which are the right heart, the upper systemic circulation, the lower systemic 
circulation, the left pulmonary artery, and the right pulmonary artery. In order to control 
the flow passing in one direction, a diode has been utilized in such a way representing heart 
valves, making the flow not come back to the heart. 
       The valve is formulated by a combination of poiseuille’s Law and the Heaviside 
function: 
           𝑄(𝑡) = [
𝑑𝑃
𝑅𝑣𝑎𝑙𝑣𝑒
] ∗ 𝐻(𝑑𝑃)……………………………………….…..………….…..(5) 
              Where H= Heaviside function 
  
        The right ventricle elastance can be utilized to simulate the time varying compliance 
of the right ventricle. It can be measured by knowing the maximum elastance, minimum 
elastance, and Double Hill function. The time varying compliance is the inverse of the right 
ventricle elastance. 
              𝐸(𝑡) = ((𝐸𝑚𝑎𝑥 −  𝐸𝑚𝑖𝑛) ∗  𝐸𝑛 (𝑡𝑛)) −  𝐸𝑚𝑖𝑛…………………...….……...…...(6) 
 
 
 The Double Hill function can be found by: 
              𝐸𝑛 (𝑡) = 1.55 ∗ [ 
(
𝑡𝑛
0.7
)
1.9
1+(
𝑡𝑛
0.7
)
1.9
 
] ∗ [ 
1
1+(
𝑡𝑛
1.17
)
21.9
 
]……………………...……….……..(7) 
             The normalized time-scale (tn) is defined by: 
              tn = 
𝑡
𝑇𝑚𝑎𝑥
………………………………………………..………………………(8) 
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The shifted heart cycle period is obtained by: 
              𝑇𝑚𝑎𝑥 = 0.2 + 0.15 ∗ 𝑡𝑐………………………...………………………………(9) 
             
The actual heart cycle period is defined as: 
𝑡𝑐 =
60
𝐻𝑅
………………………………….……………………………………(10) 
Where HR = heart rate 
       After calculating the right ventricle elastance, the time varying compliance is 
obtainable, and can be used in the system of differential equations. 
 
𝐶𝑟𝑣(𝑡) =
1
𝐸(𝑡)
………………………………………………………………..(11) 
       Figure (9) displays the elastance of the right ventricle with the heart rate of 120 beats 
/ se cond.   
                 
Figure 9: Elastance of the right ventricle 
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        Since the lumped parameter model of the Fontan procedure mimics Ohm’s law, 
Kirchhoff's Current Law (KCL) and Kirchhoff's Voltage Law (KVL) have been used to 
formulate the differential equations. 
       The system of ordinary differential equations is set as follow: 
               
𝑑𝑝𝑟𝑎(𝑡)
𝑑𝑡
=
𝑝𝑙𝑝𝑐(𝑡)− 𝑝𝑟𝑎(𝑡)
𝑅𝑙𝑝𝑣 ∗𝐶𝑟𝑎
+
𝑝𝑟𝑝𝑐(𝑡)− 𝑝𝑟𝑎(𝑡)
𝑅𝑟𝑝𝑣 ∗𝐶𝑟𝑎
+
𝑝𝑟𝑎(𝑡)− 𝑝𝑟𝑣(𝑡)
𝑅𝑡𝑣 ∗𝐶𝑟𝑎
∗ 𝐻(𝑝𝑟𝑎(𝑡) −
 𝑝𝑟𝑣(𝑡))……………………………………………………………….………………..(12) 
 
 
𝑑𝑝𝑟𝑣(𝑡)
𝑑𝑡
=
− 𝑑 𝐶𝑟𝑣(𝑡)
𝐶𝑟𝑣 ∗ 𝑑𝑡
∗ 𝑝𝑟𝑣(𝑡)  +
𝑝𝑟𝑎(𝑡) −  𝑝𝑟𝑣(𝑡)
𝑅𝑡𝑣 ∗ 𝐶𝑟𝑎
∗ 𝐻(𝑝𝑟𝑎(𝑡) −  𝑝𝑟𝑣(𝑡)) 
−
𝑝𝑟𝑣(𝑡)− 𝑝𝑟𝑎𝑜(𝑡)
𝑅𝑡𝑣 ∗𝐶𝑟𝑎
∗ 𝐻(𝑝𝑟𝑣(𝑡) − 𝑝𝑎𝑜(𝑡))……………………………….……..(13)  
        
𝑑𝑝𝑎𝑜(𝑡)
𝑑𝑡
=  
𝑝𝑟𝑣(𝑡)− 𝑃𝑎𝑜(𝑡)
𝑅𝑡𝑣 ∗𝐶𝑟𝑎
∗ 𝐻(𝑝𝑟𝑣(𝑡) −  𝑝𝑎𝑜(𝑡)) − 
𝑄𝑠𝑐𝑎(𝑡)
𝐶𝑎𝑜
−  
𝑄𝑠𝑐𝑎(𝑡)
𝐶𝑎𝑜
 ………....(14) 
 
𝑑𝑄𝑠𝑐𝑎(𝑡)
𝑑𝑡
=
𝑝𝑎𝑜(𝑡)
𝐿𝑠𝑐𝑎
− 
𝑝𝑠𝑐(𝑡)
𝐿𝑠𝑐𝑎
 
𝑅𝑠𝑐𝑎∗𝑄𝑠𝑐𝑎(𝑡)
𝐿𝑠𝑐𝑎
………………………………….……..(15) 
 
  
𝑑𝑝𝑠𝑐(𝑡)
𝑑𝑡
=  
𝑄𝑠𝑐𝑎(𝑡)
𝐶𝑠𝑐
−  
𝑝𝑠𝑐(𝑡)− 𝑃𝑗(𝑡)
𝑅𝑠𝑣𝑐 ∗𝐶𝑠𝑐
…………………………………………….(16) 
 
𝑑𝑄𝑖𝑐𝑎(𝑡)
𝑑𝑡
=
𝑝𝑎𝑜(𝑡)
𝐿𝑖𝑐𝑎
−  
𝑝𝑖𝑐(𝑡)
𝐿𝑖𝑐𝑎
−
𝑅𝑖𝑐𝑎∗𝑄𝑖𝑐𝑎(𝑡)
𝐿𝑖𝑐𝑎
……………………………………...(17) 
 
𝑑𝑝𝑖𝑐(𝑡)
𝑑𝑡
=  
𝑄𝑖𝑐𝑎(𝑡)
𝐶𝑖𝑐
−  
𝑝𝑖𝑐(𝑡)− 𝑃𝑗(𝑡)
𝑅𝑖𝑣𝑐 ∗𝐶𝑠𝑐
………………………………….…………..(18) 
             
𝑑𝑄𝑙𝑝𝑎(𝑡)
𝑑𝑡
=
𝑝𝑗(𝑡)
𝐿𝑙𝑝𝑎
−  
𝑝𝑙𝑝𝑐(𝑡)
𝐿𝑙𝑝𝑎
 −  
𝑅𝑙𝑝𝑎∗𝑄𝑙𝑝𝑎(𝑡)
𝐿𝑙𝑝𝑎
……………………………………(19) 
 
𝑑𝑝𝑙𝑝𝑐(𝑡)
𝑑𝑡
=  
𝑄𝑙𝑝𝑎(𝑡)
𝐶𝑙𝑝𝑐
−  
𝑝𝑙𝑝𝑐(𝑡)− 𝑃𝑟𝑎(𝑡)
𝑅𝑙𝑝𝑣 ∗𝐶𝑙𝑝𝑐
…………………………...…..…………(20) 
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𝑑𝑄𝑟𝑝𝑎(𝑡)
𝑑𝑡
=
𝑝𝑗(𝑡)
𝐿𝑟𝑝𝑎
−  
𝑝𝑟𝑝𝑐(𝑡)
𝐿𝑟𝑝𝑎
− 
𝑅𝑟𝑝𝑎∗𝑄𝑟𝑝𝑎(𝑡)
𝐿𝑟𝑝𝑎
…………………….….......…....…...(21) 
 
𝑑𝑝𝑟𝑝𝑐(𝑡)
𝑑𝑡
=  
𝑄𝑟𝑝𝑎(𝑡)
𝐶𝑟𝑝𝑐
− 
𝑝𝑟𝑝𝑐(𝑡)− 𝑃𝑟𝑎(𝑡)
𝑅𝑟𝑝𝑣 ∗𝐶𝑟𝑝𝑐
……………………………….……….…..(22) 
 
𝑑𝑝𝑗(𝑡)
𝑑𝑡
=
𝑝𝑠𝑐(𝑡)− 𝑃𝑗(𝑡)
𝑅𝑠𝑣𝑐 ∗𝐶𝑗
+ 
𝑝𝑖𝑐(𝑡)− 𝑃𝑗(𝑡)
𝑅𝑖𝑣𝑐 ∗𝐶𝑗
−  
𝑄𝑙𝑝𝑎(𝑡)
𝐶𝑗
−  
𝑄𝑟𝑝𝑎(𝑡)
𝐶𝑗
……………...........….(23)      
             
 Adding the Injection jet Shunt will increase the system’s degree of freedom to (13 DOF).  
𝑑𝑄𝑖𝑗𝑠(𝑡)
𝑑𝑡
= −
𝑝𝑗(𝑡)
𝐿𝑖𝑗𝑠
+ 
𝑝𝑎𝑜(𝑡)
𝐿𝑖𝑗𝑠
−  
𝑅𝑖𝑗𝑠∗𝑄𝑖𝑗𝑠(𝑡)
𝐿𝑖𝑗𝑠
………………………….………......(24) 
 
  Figure (10) shows the IJS added to the Lumped Parameter Model. 
 
 
 
Figure 10: Lumped Parameter Model with IJS 
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      As mentioned previously, the system of differential equations is solved by Runge-
Kutta 4th order solver. This system has to have initial values. If not, the solution will be 
trivial.  
Lumped Parameter Model (LPM) Coupled to the Computational Fluid Dynamics 
(CFD) 
 
        The system of equations governing the Fontan procedure analysis is set to provide the 
blood pressure and the blood flow in the right ventricle, superior vena cava, inferior vena 
cava, right pulmonary artery, and the left pulmonary artery. These blood pressure and blood 
flow data have been utilized as boundary conditions to simulate a transient analysis of the 
Fontan procedure by the commercial software known as Star CCM+ which is a 
computational fluid dynamics (CFD) solver established by CD-Adapco [32].  
       Computational fluid dynamics analysis would give an adequate knowledge about the 
physiology of the Fontan operation. This will help understand the blood pressure and the 
blood flow attributes all over the Fontan model as well as adding the Injection Jet Shunt 
(IJS) to the baseline model. After the Fontan procedure is being simulated, the CFD will 
provide new pressure and flow data. These data have been coupled to the Lumped 
Parameter Model (LPM) to provide time averaged solution that provides new pressure and 
flow curves used in the new boundary conditions to simulate the Fontan operation again. 
This process is being repeated consecutively so that the residuals will be decreased to the 
minimal level.  
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Figure 11: Coupling process 
Figure 12: CFD-LPM coupling process 
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CFD Solver and Fluid Domain Meshing 
 
        The 3D CAD model was built by CATIA V5 as described previously. The model is 
imported to the CFD solver to start setting the physical parameters in the CFD setup of the 
Fontan operation. The CAD repair tool was used to fix any inconsistency that the model 
might have. The CAD repair is necessary to avoid any complications that might happen 
while meshing the model. Afterwards, the mesh, the discretized illustration of the 
computational volume that the solvers utilize to deliver a numerical solution, was generated 
by the Star CCM+ meshing tool.  Surface remesher with the polyhedral volume, thin, prism 
layer mesher models were chosen as well as the automatic surface repair. Automatic 
surface repair was enabled to improve and optimize the mesh quality which could affect 
the numerical solution if it is not precise enough. The cell size of the baseline model and 
the IJS model was set to 3 mm with a total number of cells of 293,010 and 349,619 
respectively. Furthermore, the physics that describe the Fontan procedure were set 
properly. The fluid domain that was set up for such a case is an incompressible Newtonian’s 
flow with viscosity material properties and blood density. The flow field solution is 
governed by the Navier-Stokes equations of mass and momentum.  
∇ ∙?̅?= 0…………………………………………………………………………………………………………(25)  
 
ρ 
𝑑?̅?
𝑑𝑡
+ ρ (∇ ∙?̅?) ?̅? = −∇𝑝 + 𝜇∇2 𝑉 + ρ 𝑓…̅…………………………………………………………(26) 
 
The blood density is set as ρ = 1060 [ 
𝑘𝑔
m3
 ], and the dynamic viscosity is 𝜇 = 
0.004 [pa.s].  
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Chapter IV 
Results and Discussion 
 
        The flow and pressure characteristics for the baseline model as well as the IJS model 
are presented in this section. The baseline model represents the physiological flow and 
pressure values for the failing Fontan procedure. The cardiac output is set at an average 
flow of 1.2 L/min. The ratio of the flow moving through the lower circulation is maintained 
at 69 percent of the total cardiac output while the ratio of the flow traveling through the 
upper circulation is kept at 31 percent of the total cardiac output.  The ratio of the flow in 
the pulmonary arteries is maintained at 50 percent each. The ratio of the pulmonary flow 
to the systemic flow (Qp/Qs) is one. The inferior vena cava pressure is equivalent to the 
failing Fontan operation.  The superior vena cava pressure is roughly analogous to the 
pressure of the inferior vena cava. The pressure at the pulmonary arteries is similar. 
        The IJS model replicates the palliative technique used in this research. The flow split 
ratio between the upper and lower circulations is preserved.  The flow split ratio between 
the pulmonary arteries is also maintained. The cardiac output increases to 1.77 L/min. The 
ratio of the pulmonary flow to the systemic flow (Qp/Qs) increases to (1.32). The increase 
in the pulmonary flow to the systemic flow ratio decreases the inferior vena cava pressure 
by 0.95 mmHg with respect to the baseline model. The pressure at the upper circulation 
decreases while the pressure at the pulmonary arteries increases. The summary of the 
results are shown below. 
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Figure 13: The baseline model pressure 
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Figure 14: Velocity field of the baseline model 
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Figure 15: The IJS model pressure 
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Figure 16: Velocity field of the IJS model 
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 Baseline IJS 
Cardiac Output (ml/s) 20 29.53 
Qu / Qs  (%) 31 30.8 
Ql / Qs  (%) 69 69.2 
Qlpa / Qp  (%) 50 50.01 
Qrpa / Qp  (%) 50 49.99 
Qp /Qs 1 1.32 
Qsvc (ml/s) 6.2 6.88 
Qivc (ml/s) 13.8 15.46 
Qlpa (ml/s) 10 14.77 
Qrpa (ml/s) 10 14.76 
Qijs (ml /s) N/A 6.88 
Table 1: Flow values in the baseline & IJS models  
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Table 2: Pressure values in the baseline & IJS models 
 
 
 
 
 
 
 Baseline IJS 
Pao (mmHg) 31.2 29.7 
Pivc (mmHg) 23.5 22.55 
P svc (mmHg) 23.2 22.1 
Prpa (mmHg) 13.5 14.03 
Plpa (mmHg) 13.5 14.03 
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Chapter V 
Conclusion – Limitation – Future Work 
 
         This research displays the Fontan Procedure baseline model as well as the IJS model. 
Catia V5 software was used to model the geometry incorporated in the CFD simulation in 
STAR CCM+ which is the second software used in this research. Furthermore, the solution 
generated by Lumped Parameter Model (LPM) is coupled to STAR CCM results in order 
to have time averaged solution that represents the convergence between the CFD and LPM. 
The coupling process also does eliminate the deviation between the results coming out of 
the CFD and the solution obtained by the lumped parameter model until the convergence 
achieved. After all the steps are done, the baseline model shows an acceptable blood 
pressure in the aorta, superior vena cava, inferior vena cava, and right and left pulmonary 
arteries. The aim of the blood flow distribution is to be 70 percent through the lower 
circulation and 30 percent through the upper circulation. Also, the aim of the blood 
distribution is to have 50 percent in the left pulmonary artery and 50 percent in the right 
pulmonary artery. This approach has been accomplished successfully. Additionally, the 
Injection Jet Shunt (IJS) model enhances the blood flow through the pulmonary arteries. It 
also reduces the inferior vena cava pressure by 0.95 mmHg.  The blood flow distribution 
is maintained through the upper circulation, lower circulation, and pulmonary arteries.  
       Moreover, the limitations of this research were the speed of the computers used to run 
the simulations and the limited time frame that was given to get this research done. To this 
end, it is recommended to use a compliant model which will assist reading the results 
coming out of the CFD more accurately. Also, testing different diameters and angles of the 
IJS is vital to enhance the results. 
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Appendices 
 
Appendix 1: Abbreviations Resulted from the Equations 
 
Emin……………………………….………………….……………….Minimum elastance 
Emax………………………………………….……………….………Maximum elastance 
Pra………………………………………………………….…………right atrium pressure 
Prv…………...………………………………………….…………..right ventricle pressure 
Pao…………………………………………………………….…………….aortic pressure 
Qsca…………………………………………….………….superior circulation artery flow 
Psc………………………………………………..…………...superior circulation pressure 
Qica……………………………………………..…………..inferior circulation artery flow 
Pic……………………………………………………………..inferior circulation pressure 
Qlpa…………………………………………………..………....left pulmonary artery flow 
Plpc……………………………………………...……..left pulmonary circulation pressure 
Prpc……………………………………………...……right pulmonary circulation pressure 
Qrpa………………………………………….………………...right pulmonary artery flow 
Pj…………………………………………...……total cavopulmonary connection pressure 
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Appendix 2:  The Fontan Procedure Model Parameters 
 
No. Parameter Value 
1 ∆t 0.000001 
2  Tmax 0.275 
3         Emax 0.5 
4 Emin 0.06 
5 𝑅𝑙𝑝𝑣  0.05 
6 𝐶𝑟𝑎 4.4 
7 𝑅𝑡𝑣  0.05 
8 𝐶𝑎𝑜 0.08 
9 𝐿𝑠𝑐𝑎 0.001 
10 𝐶𝑠𝑐 2.66 
11 𝑅𝑠𝑣𝑐  0.9 
12 𝐿𝑖𝑐𝑎 0.001 
13 𝑅𝑖𝑐𝑎 2.66 
14 𝐶𝑖𝑐 2.66 
15 𝑅𝑖𝑣𝑐  0.4 
16 𝐿𝑙𝑝𝑎 0.001 
17 𝐶𝑙𝑝𝑐 2.66 
18 𝐿𝑟𝑝𝑎 0.001 
19 𝑅𝑟𝑝𝑎 0.1 
20 𝐶𝑟𝑝𝑐 2.66 
21 𝑅𝑟𝑝𝑣  2.66 
22 𝑅𝑙𝑝𝑎  0.1 
23 𝑅𝑠𝑐𝑎  3.25 
24 𝑅𝑝𝑣  0.05 
25 𝐶𝑗 0.1 
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Appendix 3: Modeling Instructions 
 
From the file menu, select New Simulation.  
In the Create New Simulation window, click Parallel on Local Host.  
Select how many nodes needed to run parallel simulation on the local machine 
Click Ok 
The simulation tree will appear. 
A. 3D CAD Model Import: 
In the Geometry tree, right click on 3D-CAD Models. 
Click New  
Right Click on 3D-Cad Models  
Select Import CAD Model 
Open the 3D-CAD model prepared to the simulation. 
The 3D-CAD model is uploaded 
Click Update 3D-CAD 
Click Close 3D-CAD 
Under the 3D-CAD Models tree, right click on 3D-CAD Model 1 
Click New Geometry Part 
Click OK on Part Creation Options 
Open Parts tree 
Right click on Body 1 
Select Repair CAD 
Change Faces to show on Start Up to All Faces in the drop down list 
Click Ok 
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Click Execute 
If errors appear, click Auto-Repair Geometry Errors 
Click Close 
Open Body 1 tree 
Open Surfaces tree 
Right click on Default 
Select Split by Angle 
Change the angle to the suitable angle to split the model 
Click Ok 
Right click on Body 1 
Click Assign Parts to Regions 
Select Body 1 
Change Create One Region for All Parts to Create a Region for Each Part 
Change Create a Boundary for Each Part to Create a Boundary for Each 
Par Surface 
Click Apply 
B. Mesh:  
Right click on Operations  
Select New  
Select Automated Mesh 
Click Parts 
Click Surface Remesher 
Click Automatic Surface Repair 
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Select Polyhedral Mesher 
Select Thin Mesher 
Select Prism Layer Mesher 
Click Ok 
Open Automated Mesh tree 
Open Default Controls tree 
Click Base Size 
Set base size value  
Right click on Automated Mesh 
Select Execute 
From the mesh menu, select Diagnostics 
Check the validity of the mesh. Any negative volumes make the mesh invalid. 
 
C. Physics Setup: 
Right click on Continua 
Select New 
Select Physics continuum 
Right click on Physics 1 
Click Select Models 
Under Space, Select Three Dimensional 
Under Time, Select Implicit Unsteady 
Under Material, select Liquid 
Under Flow, select Segregated Flow 
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Under Equation of State, select Constant Density  
Under Viscous Regime, select Laminar 
Click close 
Open Models tree  
Open Liquid tree 
Right click Rename 
Change Liquid name to Blood 
Open Blood tree 
Open Material Properties tree 
Open Density tree 
Click Constant  
Set density value 
Open Dynamic Viscosity tree 
Click constant 
Set Dynamic viscosity value 
D. Setting Boundary conditions: 
Open tool tree 
Right click on Tables 
Select New Table 
Select File Table 
Upload the table having the boundary conditions data 
Open Regions tree 
Open Body 1 tree 
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Open Boundaries tree 
Right click on Default 
Click Edit 
Under Type, change the boundary condition type for both inlets and outlets 
from the drop down list. 
Open Physics Values tree 
Select table name from the drop down list 
Select table data from the drop down list 
Click Close 
E. Setting Reports: 
Right click on Derived Parts 
Select New Part 
Select Section 
Select Constrained Plane 
Set the locations needed to take reports from 
Click Create 
Right click on Reports 
Select New Report  
Select the desired field report  
Right click on the selected report 
Click Edit 
Under parts, select the constrained plane created in the previous step 
F. Setting Plots: 
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Right click on the selected report 
Click Create Monitor and Plot from Report 
Select Single Plot to create one single plot file 
G. Setting Streamline: 
Right click on Derived Parts 
Select New Part 
Select Streamline 
Under Seed Parts, select Regions 
Click Ok 
Select Create 
H. Scene Creation: 
H.1 Scalar Scene: 
Right click on Scenes 
Select Scalar  
Open Scalar 1 tree 
Open Displayer tree 
Open Outline 1 tree 
Right click on Parts 
Select Edit 
Open Regions tree 
Select Body 1 
Click Ok 
Open Scalar 1 
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Right click on Parts 
Select Edit 
Open Regions tree 
Select Body 1 
Click Ok 
Right click on Scalar Field 
Select Edit 
Under Function, select the scalar flied 
Click Close 
 
H.2 Vector Scene: 
Right click on Scenes 
Select Vector  
Open Vector 1 tree 
Open Displayer tree 
Open Outline 1 tree 
Right click on Parts 
Select Edit 
Open Regions tree 
Select Body 1 
Click Ok 
Open Vector 1 
Right click on Parts 
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Select Edit 
Open Regions tree 
Select Body 1 
Click Ok 
Right click on Vector Field 
Select Edit 
Under Function, select the Vector flied 
Click Close 
I. Solver Setting 
Open Solvers tree 
Click Implicit Unsteady 
Set the time step size 
Click Close 
Open Stopping Criteria  
Select Maximum Inner Iterations 
Set the number of iterations per time step 
Select Maximum Physical Time 
Set the time needed to obtain a stable solution 
Select Maximum Steps 
Disable the maximum steps  
From the Solution menu, select Initialize Solution 
The solution is initialized and ready to run. 
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Appendix 4: CFD-LPM Coupling Charts-Baseline Model 
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Appendix 5: CFD-LPM Coupling Charts-IJS Model 
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Appendix 6: LPM Pressure & Flow Charts - Baseline Model 
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Appendix 7: LPM Pressure & Flow Charts - IJS Model 
 
 
 
